`
Home

Social Media Monitoring Page for Celgene

latest blog entries

Loading...
Branding...

latest headlines for company on cafepharma

Motley Fool
Wed, 06/05/13 - 12:24 pm
Motley Fool
Sun, 05/26/13 - 11:20 am
Investors Business Daily
Sat, 05/18/13 - 11:53 am
The Street
Sat, 05/04/13 - 10:19 am
tags: Celgene
The Street
Sat, 04/27/13 - 9:57 am
tags: Celgene
Yahoo/AP
Sat, 04/27/13 - 9:56 am
tags: Celgene

Last 30 twitter posts

Latest Health Message Board Posts

... insurance doesn't have to cover it because it's a trial. :] So excited! If anyone else is interested, it's done by a company called Celgene.__________________ Diagnosed with Crohn's: January 2008 Surgeries: Gastrostomy [March 2011, Reversal September 2011 ...
Posted by: Arno at 2013-03-10 14:15:00 on healingwell.com
... doesn't have to cover it because it's a trial. :] So excited! If anyone else is interested, it's done by a company called Celgene. I looked into the celgene injections for me too. Apparantly it is not the same one as ziggy. Since there is no chemo, there ...
Posted by: Arno at 2013-03-09 11:01:00 on healingwell.com
... though. Chemo plays a major roll in these past trials, as you can't kill the crohn's otherwise. I really hope the celgene injections has great healing properties though - please keep us posted on your results! Yeah, but it's not nearly as risky and when ...
Posted by: Nikodicreta at 2013-01-04 06:00:00 on medhelp.org
... Biotechnology. Scher reported financial links with Cougar Biotechnology and Veridex. Smith reported financial links with Biogen Idec, Celgene, Cephalon, Genentech, GlaxoSmithKline, and Spectrum Pharmaceuticals. Primary source: Journal of Clinical Oncology
Posted by: my little penguin</span> at 2012-12-12 04:47:00 on chronsforum.com
... from Schering Canada. Dr. Feagan reported relationships with Abbott, UCB Pharma, Centocor, Schering-Plough, Novartis, Celgene, Chemocentryx, Procter & Gamble Pharmaceuticals, Otsuka America, Berlex, Santarus, Synta, Genentech, PDL Biopharma, and Elan ...
Posted by: Tall Allen at 2011-11-24 00:04:00 on healthboards.com
... , EMD Serono, Genentech, Teva Neuroscience, Genmab, Medicinova, Actelion, Allozyne, Sanofi-Aventis, Acorda, Questcor, Avanir, Roche, Celgene, Abbott, Pfizer, Morphosys; grants/grants pending, NIH, NMSS, Acorda, Biogen Idec, Teva, Novartis, Sanofi-Aventis ...
Posted by: scotishcanadian at 2011-07-15 13:47:00 on chronsforum.com
Jim, yesterday Celgene canceled their clinical trial of Revlimid+docetaxel vs placebo+docetaxel, because it didn't confer a survival benefit. It doesn't prove that Revlimid won't work as part of a ...
Posted by: Mr. Izzy at 2011-07-14 14:02:00 on chronsforum.com
... multiple myeloma (a cancer of the blood), 7 years after its efficacy had already been confirmed in the medical literature. And Celgene took advantage of "off-label" marketing opportunities to promote the drug in advance of its FDA approval for the myeloma ...
Posted by: scotishcanadian at 2011-07-14 13:37:00 on chronsforum.com
... the first time for producing the drug and remaining silent about the birth defects. Celgene Corp, by the way, is an interesting company. In July 1998, Celgene received approval from the FDA to market Thalomid (thalidomide). They set the price to something ...
Posted by: robertC at 2011-06-09 11:10:00 on healingwell.com